Injectables are the most established option and are usually self-administered weekly in the belly, outer thighs, buttocks, or the back of the arms
Heindel JJ, Howard S, Agay-Shay K, Arrebola JP, Audouze K, Babin PJ, Barouki R, Bansal A, Blanc E, Cave MC, Chatterjee S, Chevalier N, Choudhury M, Collier D, Connolly L, Coumoul X, Garruti G, Gilbertson M, Hoepner LA, Holloway AC, Howell G, Kassotis CD, Kay MK, Kim MJ, Lagadic-Gossmann D, Langouet S, Legrand A, Li Z, Le Mentec H, Lind L, Lind PM, Lustig RH , Martin-Chouly C, Munic Kos V, Podechard N, Roepke TA, Sargis RM, Starling A, Tomlinson CR, Touma C, Vondracek J, Vom Saal F, Blumberg B
Hypotension (low blood pressure) and syncope (loss of consciousness due to low blood pressure)
Market leader Lilly is developing its own amylin analogue called eloralintide that's already in Phase 3 trials
harms of certain additives, industrial toxins, or packaging contaminants